Interactors | Protein name | Directionality | Classification | |
---|---|---|---|---|
1 | ADM-CALCRL+GPER1+RAMP3 | ADML_HUMAN - | Ligand-Receptor | Signaling by Adrenomedullin |
2 | AKR1C3-PTGFR | - PF2R_HUMAN | Ligand-Receptor | Signaling by Prostaglandin |
3 | ALDH1A1-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
4 | ALDH1A1-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
5 | ALDH1A1-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
6 | ALDH1A1-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
7 | ALDH1A1-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
8 | ALDH1A1-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
9 | ALDH1A1-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
10 | ALDH1A1-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
11 | ALDH1A1-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
12 | ALDH1A2-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
13 | ALDH1A2-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
14 | ALDH1A2-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
15 | ALDH1A2-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
16 | ALDH1A2-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
17 | ALDH1A2-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
18 | ALDH1A2-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
19 | ALDH1A2-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
20 | ALDH1A2-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
21 | ALDH1A3-CRABP2+RARA | - | Ligand-Receptor | Signaling by Retinoic Acid |
22 | ALDH1A3-CRABP2+RARA+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
23 | ALDH1A3-CRABP2+RARB | - | Ligand-Receptor | Signaling by Retinoic Acid |
24 | ALDH1A3-CRABP2+RARB+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
25 | ALDH1A3-CRABP2+RARG | - | Ligand-Receptor | Signaling by Retinoic Acid |
26 | ALDH1A3-CRABP2+RARG+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
27 | ALDH1A3-CRABP2+RXRA | - | Ligand-Receptor | Signaling by Retinoic Acid |
28 | ALDH1A3-CRABP2+RXRB | - | Ligand-Receptor | Signaling by Retinoic Acid |
29 | ALDH1A3-CRABP2+RXRG | - | Ligand-Receptor | Signaling by Retinoic Acid |
30 | ALOX12-FPR2 | - FPR2_HUMAN | Ligand-Receptor | Signaling by Lipoxin/Leukotriene |
31 | ANXA1-FPR1 | ANXA1_HUMAN - FPR1_HUMAN | Ligand-Receptor | Signaling by Annexin |
32 | ANXA1-FPR2 | ANXA1_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by Annexin |
33 | APP-CD74 | A4_HUMAN - HG2A_HUMAN | Ligand-Receptor | Signaling by Amyloid-beta precursor protein |
34 | APP-FPR2 | A4_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by Amyloid-beta precursor protein |
35 | BMP10-ACVR2A+ACVRL1 | BMP10_HUMAN - | Ligand-Receptor | Signaling by BMP |
36 | CALCA-CALCRL+RAMP1 | CALC_HUMAN - | Ligand-Receptor | Signaling by Calcitonin |
37 | CCL3-CCR1 | CCL3_HUMAN - CCR1_HUMAN | Ligand-Receptor | Signaling by Chemokines |
38 | CCL3-CCR3 | CCL3_HUMAN - CCR3_HUMAN | Ligand-Receptor | Signaling by Chemokines |
39 | CCL3-CCR5 | CCL3_HUMAN - CCR5_HUMAN | Ligand-Receptor | Signaling by Chemokines |
40 | CCL5-CCR1 | CCL5_HUMAN - CCR1_HUMAN | Ligand-Receptor | Signaling by Chemokines |
41 | CCL5-CCR3 | CCL5_HUMAN - CCR3_HUMAN | Ligand-Receptor | Signaling by Chemokines |
42 | CCL5-CCR5 | CCL5_HUMAN - CCR5_HUMAN | Ligand-Receptor | Signaling by Chemokines |
43 | CD1D-LILRB2 | CD1D_HUMAN - LIRB2_HUMAN | Ligand-Receptor | |
44 | COL1A1-ITGA10+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
45 | COL1A1-ITGA11+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
46 | COL1A1-ITGA1+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
47 | COL1A1-ITGA2+ITGB1 | CO1A1_HUMAN - | Adhesion-Adhesion | Adhesion by Collagen/Integrin |
48 | CTSG-FPR1 | CATG_HUMAN - FPR1_HUMAN | Ligand-Receptor | Signaling by Cathepsin |
49 | DAGLA-CNR1 | - CNR1_HUMAN | Ligand-Receptor | Signaling by Arachidonoylglycerol |
50 | DAGLA-CNR2 | - CNR2_HUMAN | Ligand-Receptor | Signaling by Arachidonoylglycerol |
51 | DBH+SLC18A1-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
52 | DBH+SLC18A1-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
53 | DBH+SLC18A1-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
54 | DBH+SLC18A1-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
55 | DBH+SLC18A2-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
56 | DBH+SLC18A2-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
57 | DBH+SLC18A2-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
58 | DBH+SLC18A2-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
59 | DBH+SLC6A2-ADRA1A | - ADA1A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
60 | DBH+SLC6A2-ADRA1B | - ADA1B_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
61 | DBH+SLC6A2-ADRA2A | - ADA2A_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
62 | DBH+SLC6A2-ADRA2C | - ADA2C_HUMAN | Ligand-Receptor | Signaling by Noradrenaline |
63 | DDC-HTR2B | - 5HT2B_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
64 | DDC-HTR4 | - 5HT4R_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
65 | DSG1-DSC3 | DSG1_HUMAN - DSC3_HUMAN | Adhesion-Adhesion | Adhesion by Desmosome |
66 | EFNB1-EPHA4 | EFNB1_HUMAN - EPHA4_HUMAN | Ligand-Receptor | Signaling by Ephrin |
67 | FGF1-FGFR2 | FGF1_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
68 | FGF10-FGFR2 | FGF10_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
69 | FGF2-FGFR2 | FGF2_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
70 | FGF22-FGFR2 | FGF22_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
71 | FGF3-FGFR2 | FGF3_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
72 | FGF7-FGFR2 | FGF7_HUMAN - FGFR2_HUMAN | Ligand-Receptor | Signaling by Fibroblast growth factor |
73 | GAD1+SLC32A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
74 | GAD1+SLC6A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
75 | GAD1+SLC6A11-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
76 | GAD1+SLC6A12-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
77 | GAD1+SLC6A13-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
78 | GAD1+SLC6A6-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
79 | GAD1+SLC6A8-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
80 | GAD2+SLC32A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
81 | GAD2+SLC6A1-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
82 | GAD2+SLC6A11-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
83 | GAD2+SLC6A12-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
84 | GAD2+SLC6A13-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
85 | GAD2+SLC6A6-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
86 | GAD2+SLC6A8-GABBR2 | - GABR2_HUMAN | Ligand-Receptor | Signaling by GABA |
87 | GAS6-MERTK | GAS6_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Growth arrest |
88 | GDF3-ACVR1B+ACVR2B | GDF3_HUMAN - | Ligand-Receptor | Signaling by Growth differentiation factor |
89 | HSD17B1-ESR1 | - ESR1_HUMAN | Ligand-Receptor | Signaling by Estradiol |
90 | HSD17B1-GPER1 | - GPER1_HUMAN | Ligand-Receptor | Signaling by Estradiol |
91 | LGALS3-MERTK | LEG3_HUMAN - MERTK_HUMAN | Ligand-Receptor | Signaling by Galectin |
92 | LGALS9-BCR+CD22+PTPRC | LEG9_HUMAN - | Ligand-Receptor | Signaling by Galectin |
93 | PDGFB-PDGFRA | PDGFB_HUMAN - PGFRA_HUMAN | Ligand-Receptor | Signaling by Platelet-derived growth factor |
94 | PDGFB-PDGFRA+PDGFRB | PDGFB_HUMAN - | Ligand-Receptor | Signaling by Platelet-derived growth factor |
95 | PDGFB-PDGFRB | PDGFB_HUMAN - PGFRB_HUMAN | Ligand-Receptor | Signaling by Platelet-derived growth factor |
96 | PF4-CXCR3 | PLF4_HUMAN - CXCR3_HUMAN | Ligand-Receptor | |
97 | POMC-MC1R | COLI_HUMAN - MSHR_HUMAN | Ligand-Receptor | Signaling by Podocalyxin-like protein |
98 | POMC-MC2R | COLI_HUMAN - ACTHR_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
99 | POMC-MC3R | COLI_HUMAN - MC3R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
100 | POMC-MC4R | COLI_HUMAN - MC4R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
101 | POMC-MC5R | COLI_HUMAN - MC5R_HUMAN | Ligand-Receptor | Signaling by Proopiomelanocortin |
102 | PRNP-ADGRG6 | APRIO_HUMAN - AGRG6_HUMAN | Ligand-Receptor | |
103 | PRXL2B-PTGFR | - PF2R_HUMAN | Ligand-Receptor | |
104 | PTHLH-PTH1R | PTHR_HUMAN - PTH1R_HUMAN | Ligand-Receptor | Signaling by Parathyroid hormone |
105 | PVR-CD96 | PVR_HUMAN - TACT_HUMAN | Ligand-Receptor | Signaling by Poliovirus receptor |
106 | SHMT1+SLC6A5-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
107 | SHMT1+SLC6A9-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
108 | SHMT2+SLC6A5-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
109 | SHMT2+SLC6A9-GLRA1+GLRB | - | Ligand-Receptor | Signaling by Glycine |
110 | SLIT2-ROBO1 | SLIT2_HUMAN - ROBO1_HUMAN | Ligand-Receptor | Signaling by SLIT and NTRK-like protein |
111 | TAFA5-FPR2 | TAFA5_HUMAN - FPR2_HUMAN | Ligand-Receptor | Signaling by TAFA |
112 | TAFA5-S1PR2 | TAFA5_HUMAN - S1PR2_HUMAN | Ligand-Receptor | Signaling by TAFA |
113 | TYR-GPR143 | - GP143_HUMAN | Ligand-Receptor | Signaling by Serotonin/Dopamine |
114 | UBASH3B-ESR1 | - ESR1_HUMAN | Ligand-Receptor | Signaling by Dehydroepiandrosterone |
115 | WNT1-FRZB | WNT1_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
116 | WNT1-FZD10+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
117 | WNT1-FZD10+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
118 | WNT1-FZD2+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
119 | WNT1-FZD2+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
120 | WNT1-FZD3+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
121 | WNT1-FZD3+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
122 | WNT1-FZD8+RYK | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
123 | WNT1-FZD9+LRP5 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
124 | WNT1-FZD9+LRP6 | WNT1_HUMAN - | Ligand-Receptor | Signaling by WNT |
125 | WNT1-SFRP4 | WNT1_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
126 | WNT11-FRZB | WNT11_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
127 | WNT11-FZD10+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
128 | WNT11-FZD10+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
129 | WNT11-FZD2+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
130 | WNT11-FZD2+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
131 | WNT11-FZD3+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
132 | WNT11-FZD3+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
133 | WNT11-FZD9+LRP5 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
134 | WNT11-FZD9+LRP6 | WNT11_HUMAN - | Ligand-Receptor | Signaling by WNT |
135 | WNT11-SFRP4 | WNT11_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
136 | WNT16-FRZB | WNT16_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
137 | WNT16-FZD10+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
138 | WNT16-FZD10+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
139 | WNT16-FZD2+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
140 | WNT16-FZD2+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
141 | WNT16-FZD3+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
142 | WNT16-FZD3+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
143 | WNT16-FZD9+LRP5 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
144 | WNT16-FZD9+LRP6 | WNT16_HUMAN - | Ligand-Receptor | Signaling by WNT |
145 | WNT16-SFRP4 | WNT16_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
146 | WNT2-FRZB | WNT2_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
147 | WNT2-FZD10+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
148 | WNT2-FZD10+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
149 | WNT2-FZD2+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
150 | WNT2-FZD2+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
151 | WNT2-FZD3+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
152 | WNT2-FZD3+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
153 | WNT2-FZD9+LRP5 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
154 | WNT2-FZD9+LRP6 | WNT2_HUMAN - | Ligand-Receptor | Signaling by WNT |
155 | WNT2-SFRP4 | WNT2_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
156 | WNT4-FRZB | WNT4_HUMAN - SFRP3_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |
157 | WNT4-FZD10+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
158 | WNT4-FZD10+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
159 | WNT4-FZD2+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
160 | WNT4-FZD2+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
161 | WNT4-FZD3+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
162 | WNT4-FZD3+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
163 | WNT4-FZD9+LRP5 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
164 | WNT4-FZD9+LRP6 | WNT4_HUMAN - | Ligand-Receptor | Signaling by WNT |
165 | WNT4-SFRP4 | WNT4_HUMAN - SFRP4_HUMAN | Ligand-Ligand | Signaling by WNT inhibition |